Technical Analysis for LPCN - Lipocine Inc.

Grade Last Price % Change Price Change
grade B 2.98 -1.65% -0.05
LPCN closed down 1.65 percent on Friday, September 13, 2019, on 87 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical LPCN trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bearish Signal Line Cross Bearish -1.65%
20 DMA Support Bullish -1.65%
1,2,3 Pullback Bullish Bullish Swing Setup -1.65%

Older signals for LPCN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Lipocine Inc., a specialty pharmaceutical company, is engaged in the development of pharmaceutical products in the areas of men's and women's health. The company offers a portfolio of proprietary product candidates that are used to produce pharmacokinetic characteristics; facilitate lower dosing requirements and bypass first-pass metabolism; reduce side effects; and eliminate gastrointestinal interactions that limit bioavailability. Its product candidates for men's health include LPCN 1021, an oral product candidate, which is in Phase III clinical trials; and LPCN 1111, an oral product candidate that is in Phase I/II clinical trials for the treatment of testosterone replacement therapy. The company's product candidates for women's health comprise LPCN 1107, which is in Phase I/II clinical trials for the prevention of preterm birth. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Chemistry Health Pharmaceutical Pharmaceutical Products Clinical Trial Alcohols Design Of Experiments Clinical Research Bypass Ketones Androstanes Testosterone Testosterone Replacement Therapy
Is LPCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.45
52 Week Low 1.04
Average Volume 162,101
200-Day Moving Average 1.8738
50-Day Moving Average 2.2776
20-Day Moving Average 2.8755
10-Day Moving Average 3.126
Average True Range 0.2346
ADX 49.38
+DI 25.644
-DI 14.4967
Chandelier Exit (Long, 3 ATRs ) 2.7462
Chandelier Exit (Short, 3 ATRs ) 2.7238
Upper Bollinger Band 3.4665
Lower Bollinger Band 2.2845
Percent B (%b) 0.59
BandWidth 41.105895
MACD Line 0.2563
MACD Signal Line 0.2826
MACD Histogram -0.0263
Fundamentals Value
Market Cap 61.33 Million
Num Shares 20.6 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -3.20
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.25
Resistance 3 (R3) 3.26 3.17 3.21
Resistance 2 (R2) 3.17 3.10 3.17 3.19
Resistance 1 (R1) 3.08 3.06 3.04 3.07 3.17
Pivot Point 2.99 2.99 2.97 2.99 2.99
Support 1 (S1) 2.90 2.92 2.86 2.89 2.79
Support 2 (S2) 2.81 2.88 2.81 2.77
Support 3 (S3) 2.72 2.81 2.76
Support 4 (S4) 2.71